Metabolic disorders are one of the fastest-growing global health challenges. Common metabolic conditions include insulin resistance, type 2 diabetes, dyslipidemia, and metabolic syndrome. They involve complex biological pathways that cannot be fully understood using model systems alone. At Bay Biosciences, we provide high-quality metabolic disorder samples to support drug discovery, biomarker development, and translational research. […]
Breast cancer remains one of the most common cancers worldwide and continues to affect millions of women each year. Because breast cancer is biologically diverse, researchers rely on well-characterized human biospecimens to investigate tumor biology, molecular alterations, biomarkers, disease progression, and treatment responses. At Bay Biosciences, we understand this need and provide high-quality breast cancer […]
High-quality biospecimens are the foundation of successful endocrine research. For studies focused on autoimmune thyroid disorders, access to fully consented and well-characterized thyroid disease samples is essential. These samples allow researchers to understand disease mechanisms, track progression, and test potential therapies. At Bay Biosciences, we provide ethically sourced, clinically annotated thyroid disorder samples to support […]
Bay Biosciences supports biomedical and translational research by providing high-quality, ethically sourced human biospecimens collected under strict regulatory standards. These biospecimens, including human tissue samples, serum, plasma, PBMCs, stool samples and other biofluids, are essential for understanding disease biology, validating drug targets, and advancing precision medicine. In clinical research, biospecimen collection generally follows two approaches: […]
Bay Biosciences provides researchers with high-quality, ethically sourced human tumor tissue samples and biospecimens designed to support rigorous oncology research. These include fresh frozen tumors, FFPE tumor samples, normal adjacent tissues, serum, plasma, and PBMCs. Across academia, biotech, and pharmaceutical R&D, the use of reliable tumor tissues for cancer research is no longer optional today. […]